CryoLife agrees to acquire JOTEC AG

CryoLife entered into a definitive agreement to acquire JOTEC AG, a German developer of endovascular stent grafts and surgical grafts, to access the $2 billion global stent graft market.

“We believe this acquisition will enable CryoLife to deliver sustained, high single-digit revenue growth, while also diversifying our revenues into a significantly larger addressable market.”cryolife.com

• 1 source
• cryolife.comCryoLife Announces Definitive Agreement to Acquire JOTEC - CryoLife, Inc.Allison ScollanOct 3, 2017

Summarized from public sources; check the original articles before acting on it.